Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Low dose omega 3 supplementation in cad

950 views

Published on

In this RC trial omega-3 fat supplementation as margarine did not bring any benefit in patients with recent myocardial infarction

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Low dose omega 3 supplementation in cad

  1. 1. www.pronutritionist.net n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction Kromhout D et al. N Engl J Med 2010; August 29. (e-pub ahead of print) Page 1 Kromhout D et al. N Engl J Med 2010; August 29. (e-pub ahead of print)
  2. 2. Page 2 Background • Resent studies have shown that supplementation with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may reduce – cardiovascular and all-cause mortality with patients with cardiac disease (GISSI-Prevenzione Investigators 1999) – the risk of fatal coronary heart disease (JELIS Study, only EPA supplementation, Yomoyoma et al. 2007) • A protective effect of the plant-derived n−3 fatty acid alpha-linolenic acid (ALA) is less studied • Cohort studies have suggested that low doses of n−3 fatty acids should be sufficient to reduce cardiovascular risk Kromhout D et al. N Engl J Med 2010; August 29. (e-pub ahead of print) www.pronutritionist.net
  3. 3. Methods (1/2) • double-blind, placebo-controlled trial • n = 4837 (age 60-80 years) – all had had a myocardial infarction and were receiving state-of-the-art antihypertensive, antithrombotic, and lipidmodifying therapy – 78 % were men • Patients were randomly assigned to four groups: – a margarine supplemented with a combination of EPA and DHA – a margarine supplemented with ALA – a margarine supplemented with EPA–DHA and ALA – a placebo margarine Page 3 Kromhout D et al. N Engl J Med 2010; August 29. (e-pub ahead of print) www.pronutritionist.net
  4. 4. Methods (2/2) • All patients were given placebo margarine during the first 4 to 6 weeks after randomization • Study duration was 40 months • The primary end point: – fatal and nonfatal cardiovascular events and cardiac interventions • Secondary end points: – incident of cardiovascular disease – fatal cardiovascular disease – fatal coronary heart disease – ventricular-arrhythmia -related events – death from any cause www.pronutritionist.netKromhout D et al. N Engl J Med 2010; August 29. (e-pub ahead of print) 4
  5. 5. Results (1/3) • mean intake of trial margarine was 18.8±4.7 g per day – 90.5% of the patients consumed a mean of 20.6±2.8 g per day • patients in EPA–DHA groups received – 226 mg of EPA and 150 mg of DHA per day • Baseline intake of EPA-DHA was 120-130 mg per day • patients in ALA groups received – 1.9 g of ALA per day • Adverse effects did not differ between the groups Page 5 Kromhout D et al. N Engl J Med 2010; August 29. (e-pub ahead of print) www.pronutritionist.net
  6. 6. Results 2/3 www.pronutritionist.netKromhout D et al. N Engl J Med 2010; August 29. (e-pub ahead of print) 6 P=0.93 P=0.20 All treatments provided as margarines
  7. 7. Results (3/3) • Low-dose supplementation with EPA–DHA or ALA did not significantly reduce the rate of major cardiovascular events – However, there was a 27% reduction in major cardiovascular events with ALA among women vs EPA-DHA or placebo • Patients with diabetes had a higher risk of all cardiovascular end points than did patients without diabetes www.pronutritionist.netKromhout D et al. N Engl J Med 2010; August 29. (e-pub ahead of print) 7
  8. 8. Discussion • Previous randomized, controlled trials involving patients with cardiac disease or at risk, did show protective effects of EPA, either with or without DHA, on various composite cardiovascular end points • This discrepancy between those trials and current one may be related to differences between patient populations in – age – sex distribution – presence or absence of a history of coronary artery disease • Authors did not speculate in their discussion if total intake of EPA+DHA c. 500 mg (376 mg from margarine & dietary baseline intake of 120-130 mg) was insufficient. In JELIS and GISSI Prevenzione studies supplementation of EPA and DHA was at least double (1 800 mg EPA and 850 mg EPA+DHA respectively). It is possible that higher intake of omega-3 fatty acids is required Page 8 Kromhout D et al. N Engl J Med 2010; August 29. (e-pub ahead of print) www.pronutritionist.net

×